Emcure Pharma, 43-Years Old Drugmaker Enters Dalal Street with 31% PremiumEmcure Pharma, 43-Years Old Drugmaker Enters Dalal Street with 31% Premium
Qualified institutional buyers were at the forefront of bidding and subscribed 92.94 times their allotted quota. On the other hand[...]